Literature DB >> 11717463

Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene.

Y X Pan1, J Xu, L Mahurter, E Bolan, M Xu, G W Pasternak.   

Abstract

Using 5' RACE, we have isolated four additional exons of the mu opioid receptor gene (Oprm), resulting in a gene spanning over 250 kb. The four new exons are contained within eight additional splice variants containing exon 11 at the 5' terminus. Exon 11, which is under the control of a previously unknown upstream promoter, and exon 12 are located approximately 10 kb and approximately 8 kb upstream from exon 1, respectively. Exon 13 and 14 are located between exons 1 and 2. The regional distributions of the variants, as determined by reverse transcription-PCR, varied among themselves and were distinct from that of MOR-1, implying region-specific RNA processing. Three variants (MOR-1H, MOR-1I, and MOR-1J) contained two potential translational start points, with the translational start point in exon 1 producing proteins identical to the original MOR-1 protein. When expressed, the receptor binding of these three variants was indistinguishable from that of MOR-1. The remaining eight proteins using the translation start point in exon 11 were all truncated, with three (MOR-1G, MOR-1M, and MOR-1N) predicting proteins of only six transmembrane domains and the rest giving proteins under 10 kDa. Western blots with an exon 11-specific antiserum revealed bands consistent with the six transmembrane domain proteins within the brain, but the shorter proteins were not detected. Thus, the MOR-1 protein can be generated by four different splice variants of the Oprm gene under the control of two physically distinct promoters. Although the truncated proteins are expressed in brain with a unique regional distribution, their functional significance remains unknown.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11717463      PMCID: PMC61171          DOI: 10.1073/pnas.241296098

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Cloning and expression of an isoform of the rat mu opioid receptor (rMOR1B) which differs in agonist induced desensitization from rMOR1.

Authors:  A Zimprich; T Simon; V Höllt
Journal:  FEBS Lett       Date:  1995-02-13       Impact factor: 4.124

2.  Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord.

Authors:  U Arvidsson; M Riedl; S Chakrabarti; J H Lee; A H Nakano; R J Dado; H H Loh; P Y Law; M W Wessendorf; R Elde
Journal:  J Neurosci       Date:  1995-05       Impact factor: 6.167

3.  Cloning and pharmacological characterization of a rat mu opioid receptor.

Authors:  R C Thompson; A Mansour; H Akil; S J Watson
Journal:  Neuron       Date:  1993-11       Impact factor: 17.173

Review 4.  Pharmacological mechanisms of opioid analgesics.

Authors:  G W Pasternak
Journal:  Clin Neuropharmacol       Date:  1993-02       Impact factor: 1.592

5.  cDNA cloning of an orphan opiate receptor gene family member and its splice variant.

Authors:  J B Wang; P S Johnson; Y Imai; A M Persico; B A Ozenberger; C M Eppler; G R Uhl
Journal:  FEBS Lett       Date:  1994-07-04       Impact factor: 4.124

6.  Expression of two variants of the human mu opioid receptor mRNA in SK-N-SH cells and human brain.

Authors:  L A Bare; E Mansson; D Yang
Journal:  FEBS Lett       Date:  1994-11-07       Impact factor: 4.124

7.  Antisense mapping the MOR-1 opioid receptor: evidence for alternative splicing and a novel morphine-6 beta-glucuronide receptor.

Authors:  G C Rossi; Y X Pan; G P Brown; G W Pasternak
Journal:  FEBS Lett       Date:  1995-08-07       Impact factor: 4.124

8.  mu opiate receptor: cDNA cloning and expression.

Authors:  J B Wang; Y Imai; C M Eppler; P Gregor; C E Spivak; G R Uhl
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

9.  Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor.

Authors:  Y X Pan; J Cheng; J Xu; G Rossi; E Jacobson; J Ryan-Moro; A I Brooks; G E Dean; K M Standifer; G W Pasternak
Journal:  Mol Pharmacol       Date:  1995-06       Impact factor: 4.436

10.  Classification of multiple morphine and enkephalin binding sites in the central nervous system.

Authors:  B L Wolozin; G W Pasternak
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

View more
  60 in total

Review 1.  Post-transcriptional regulation of opioid receptors in the nervous system.

Authors:  Li-Na Wei; Ping-Yee Law; Horace H Loh
Journal:  Front Biosci       Date:  2004-05-01

Review 2.  mRNA transcript diversity creates new opportunities for pharmacological intervention.

Authors:  Elizabeth S Barrie; Ryan M Smith; Jonathan C Sanford; Wolfgang Sadee
Journal:  Mol Pharmacol       Date:  2012-02-07       Impact factor: 4.436

3.  Synthesis and evaluation of aryl-naloxamide opiate analgesics targeting truncated exon 11-associated μ opioid receptor (MOR-1) splice variants.

Authors:  Susruta Majumdar; Joan Subrath; Valerie Le Rouzic; Lisa Polikar; Maxim Burgman; Kuni Nagakura; Julie Ocampo; Nathan Haselton; Anna R Pasternak; Steven Grinnell; Ying-Xian Pan; Gavril W Pasternak
Journal:  J Med Chem       Date:  2012-07-16       Impact factor: 7.446

4.  Splice variation of the mu-opioid receptor and its effect on the action of opioids.

Authors:  Sophy K Gretton; Joanne Droney
Journal:  Br J Pain       Date:  2014-11

Review 5.  MicroRNAs in opioid pharmacology.

Authors:  Cheol Kyu Hwang; Yadav Wagley; Ping-Yee Law; Li-Na Wei; Horace H Loh
Journal:  J Neuroimmune Pharmacol       Date:  2011-11-09       Impact factor: 4.147

6.  Molecular basis of cellular localization of poly C binding protein 1 in neuronal cells.

Authors:  Andrea M Berry; Kelly E Flock; Horace H Loh; Jane L Ko
Journal:  Biochem Biophys Res Commun       Date:  2006-09-12       Impact factor: 3.575

7.  Bioinformatic analysis of the human mu opioid receptor (OPRM1) splice and polymorphic variants.

Authors:  Lili Xin; Zaijie Jim Wang
Journal:  AAPS PharmSci       Date:  2002

8.  Isolation and characterization of new exon 11-associated N-terminal splice variants of the human mu opioid receptor gene.

Authors:  Jin Xu; Mingming Xu; Yasmin L Hurd; Gavril W Pasternak; Ying-Xian Pan
Journal:  J Neurochem       Date:  2008-12-10       Impact factor: 5.372

Review 9.  μ-Opioid receptor 6-transmembrane isoform: A potential therapeutic target for new effective opioids.

Authors:  Marino Convertino; Alexander Samoshkin; Josee Gauthier; Michael S Gold; William Maixner; Nikolay V Dokholyan; Luda Diatchenko
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-12-06       Impact factor: 5.067

10.  Effects of trichostatin A on neuronal mu-opioid receptor gene expression.

Authors:  Ying-Chih Lin; Kelly E Flock; Ryan J Cook; Amanda J Hunkele; Horace H Loh; Jane L Ko
Journal:  Brain Res       Date:  2008-10-11       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.